ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2021

November 5-9, 2021. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1612
    Factors Associated with COVID-19 Vaccine Hesitancy Among Individuals with Rheumatic Disease
  • Abstract Number: 1602
    Factors Associated with COVID-19 Vaccine Hesitancy in Rheumatology Outpatients in New York City
  • Abstract Number: 1297
    Factors Associated with Employment and Work Disability in Patients with SLE: A Nested Case-control Study
  • Abstract Number: 0361
    Factors Associated with Engaging in Physical Activity in Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS)
  • Abstract Number: 1141
    Factors Associated with Fragility Fracture in Patients with Systemic Mastocytosis: Data from an Inception Cohort in a Single Centre
  • Abstract Number: 0360
    Factors Associated with Pain Intensity in Axial Spondyloarthritis. Results from the EuropeanMap of Axial Spondyloarthritis (EMAS)
  • Abstract Number: 0476
    Factors Associated with Pain Reduction and Improved Well-Being Among Fibromyalgia Patients Using Medical Cannabis
  • Abstract Number: 1723
    Factors Associated with Postpartum Flare in Women with Lupus
  • Abstract Number: 0437
    Factors Associated with Reduced Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) Treated with Rituximab
  • Abstract Number: 0936
    Factors Associated with the Development of Anti-drug Antibodies to Tumour Necrosis Factor Inhibitors in Patients with Axial Spondyloarthritis; A Two Year Follow-up Study
  • Abstract Number: 1256
    Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
  • Abstract Number: 1026
    Factors Impacting Likelihood of Discontinuing Immunosuppression in Adult Dermatomyositis: A Single-Center Study
  • Abstract Number: 0409
    Factors Predicting Mortality in an Indian Cohort of Systemic Sclerosis
  • Abstract Number: 1260
    Factors That Impact Medication Adherence in Hospitalized Patients with Systemic Lupus Erythematosus
  • Abstract Number: 0392
    Faecal Incontinence in Scleroderma: Prevalence, Impact and Response to Sacral Neuromodulation in an Single Centre Observational Cohort
  • Abstract Number: 1849
    False Positive Anti-Topoisomerase I (Scl-70) Antibody Results: A Case Series from a Scleroderma Referral Center
  • Abstract Number: PP09
    Family Planning while Living with Rheumatoid Arthritis
  • Abstract Number: 1437
    Fat and Fibrosis: A Novel Developmental Gene in Systemic Sclerosis
  • Abstract Number: 0230
    Fatigue and Inflammation in Rheumatoid Arthritis Are Already Disconnected Before Clinical Arthritis Develops
  • Abstract Number: 1678
    Favorable Balance of Benefit and Harm of Long-Term, Low Dose Prednisolone Added to Standard Treatment in Rheumatoid Arthritis Patients Aged 65+: The Pragmatic, Multicenter, Placebo-Controlled GLORIA Trial
  • Abstract Number: 0233
    Feasibility and Acceptability of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change
  • Abstract Number: 1052
    Female Reproductive Factors and Risk of Joint Replacement Arthroplasty of the Knee and Hip Due to Osteoarthritis in Postmenopausal Women: A Nationwide Cohort Study of 1.36 Million Women
  • Abstract Number: 0510
    Fibrinogen Modified with Malondialdehyde-Acetaldehyde Adduct (MAA) And/or Citrulline (CIT) Induces Unique Cellular Responses in Human RA Synoviocytes
  • Abstract Number: 0120
    Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis
  • Abstract Number: PP12
    Fighting for the Care We Deserve: My Experience as a Latina Patient-Researcher During the COVID-19 Pandemic
  • Abstract Number: PP05
    Fighting Health-Related Misinformation Using Social Media / How Creating an Online Group for Patients with Relapsing Polychondritis — and Moderating It with Health Professionals — Helps Spread Reliable and Empowering Information
  • Abstract Number: 0928
    Filgotinib Treatment Results in Reduction of Inflammatory and Matrix Remodeling Biomarkers Associated with Disease in Patients with Ankylosing Spondylitis
  • Abstract Number: 0069
    First and Recurrent Thrombosis Risk After 3842 Patient-Years of Follow-Up: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (
  • Abstract Number: 0242
    FiRst Line Options for Systemic JIA Treatment (FROST): Results from a Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Consensus Treatment Plan Observational Study
  • Abstract Number: 0099
    First Results of the BELCOMID Study: BELgian Cohort Study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)
  • Abstract Number: 1288
    First Year Infection Risk in SLE Patients Treated with Rituximab versus Standard of Care Treatment: Results from the British Isles Lupus Assessment Group Biologics Registry (BILAG-BR)
  • Abstract Number: 1771
    First-in-Human Safety, Pharmacokinetic and Pharmacodynamic Study of Escalating Single- and Multiple-Doses of BMS-986256, a Novel, Potent, Oral Inhibitor of TLR7 and TLR8
  • Abstract Number: 1262
    Fish Oil Supplementation and Pro-inflammatory and Pro-Resolving Lipid Mediators in Patients with and Without Systemic Lupus Erythematosus
  • Abstract Number: 0836
    Flare After Switching from Intravenous Tocilizumab to Subcutaneous Formulation in Patients with Rheumatoid Arthritis
  • Abstract Number: 1550
    Flares and Side Effects After COVID-19 Vaccination in Patients with Rheumatic Diseases
  • Abstract Number: 0117
    Flares Following Herpes Zoster Recombinant Zoster Vaccination Among Adults Age ≥50 Years with Immune Mediated Inflammatory Diseases in the United States
  • Abstract Number: 0698
    Flow Cytometry and Sorting of Single Antibody Secreting Cells from Frozen Muscle Tissue
  • Abstract Number: 0644
    Follow-up Scheduling Appears Essential for Success of Rheumatology High Blood Pressure Protocol Across Health Systems
  • Abstract Number: 1142
    For Vulnerable Population Treated at a Community Health Center (CHC), Primary Care Physician (PCP) Turnover Should Be Included in Social Determinants of Health (SDH) on Non-completing Osteoporosis Treatment
  • Abstract Number: 1139
    Fracture Liaison Service Outcomes at a Southern California County Hospital Highlights Need for Health System Improvements
  • Abstract Number: 1140
    Fracture Risk in DXA-Appropriate Patients on Glucocorticoids: Is Everyone Tested According to Screening Guidelines?
  • Abstract Number: 1267
    Frailty and Emergency Department Utilization in Systemic Lupus Erythematosus: An Administrative Claims Data Analysis
  • Abstract Number: 0078
    Frequency and Clinical Characteristics of Secondary Antiphospholipid Syndrome in Systemic Lupus Erythematosus: The Georgia Lupus Registry
  • Abstract Number: 1210
    Frequency of Anterior Atlanto-Axial Subluxation in Patients with Rheumatoid Arthritis
  • Abstract Number: 0483
    Frequent Use of Prescription Oral NSAIDs Among People with Knee or Hip Osteoarthritis Despite Contraindications to or Precautions with NSAIDs
  • Abstract Number: 0542
    Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis
  • Abstract Number: 0456
    Functional Connectivity, Enhanced Blood-Brain Barrier Leakage and Cognitive Impairment in Systemic Lupus Erythematosus
  • Abstract Number: 1494
    Functional Effects of a Lupus-associated PRKG1 Variant on the RhoA-ROCK Pathway and Response to Type I Interferon
  • Abstract Number: 1838
    Further Construct Validation of the
Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences